Tech & industry

  • Ultrasound ‘helmet’ could treat Parkinson’s without surgery, study finds

    An ultrasound helmet that can target brain areas 1,000 times smaller than previous ultrasound methods may offer a non-invasive alternative to surgery for Parkinson’s disease. The device directs mechanical pulses to regions as small as a grain of rice in the brain, potentially replacing deep brain stimulation (DBS). DBS requires electrodes to be surgically implanted [...]

  • Neuralink performs successful brain implants in spinal injury patients

    Two people in Toronto have become the first in Canada to receive Neuralink’s brain-computer interface implants. The procedures, carried out at University Health Network (UHN) on 27 August and 3 September, involved patients with cervical spinal cord injuries – damage to the neck that can cause paralysis in the arms and legs. Each patient received [...]

  • Round up: AI co-pilot boosts non-invasive brain-computer interface, and more

    Neuro Rehab Times explores the latest developments in the world of neurology and neurorehabilitation. Gut immune system mouse model of Alzheimer’s provided new target for therapeutics The gut immune system is altered in a mouse model of Alzheimer’s, new research has found. The research shows that some immune cells in the gut travel along the [...]

  • NHS AI tool will help 50% of stroke patients recover

    Half of all people who experience a stroke in England will now recover thanks to an AI scanning system rolled out across all 107 NHS stroke centres. The software analyses CT brain scans in about a minute, quickly telling doctors if they need to perform emergency surgery or give drugs – and can triple the [...]

  • Researchers pioneer 3D-printed stem cell scaffolds to aid spinal cord injury recovery

    Rats with completely severed spinal cords regained function after receiving 3D-printed stem cell scaffolds in a breakthrough that could pave the way for new treatments. The approach combines 3D printing, stem cell biology and lab-grown tissues to develop a potential therapy for spinal cord injuries – damage to the bundle of nerves running through the [...]

  • VHS clip gives MND patient back her natural speech

    An MND patient who lost her voice 25 years ago can now speak again after AI rebuilt it from an eight-second VHS clip. Sarah Ezekiel, 59, from Hendon in London, was left unable to speak or use her hands when motor neurone disease (MND) – a condition that damages the brain and nerves – struck [...]

  • FDA gives go ahead for ONWARD Medical spinal study

    The FDA has approved a clinical study of an implantable device designed to stabilise blood pressure in people with spinal cord injury. The ARC-IM System, a neurostimulation device, will be tested in the Empower BP pivotal study across about 20 research centres, with patient enrolment expected before the end of 2025. Blood pressure instability affects [...]

  • Business Roundup: Advancing new therapies for Parkinson’s disease and more

    Neuro Rehab Times explores the latest business and pharmaceutical developments in the world of neuro-rehabilitation. US$32m to advance left atrial appendage occlusion technology Medical device company Conformal Medical, has raised US$32m to advance its left atrial appendage occlusion technology. The funds will support the enrolment of the company's ongoing CONFORM Pivotal Trial and [...]

  • AI speeds up triage for stroke patients

    Stroke patients at an English hospital are getting quicker diagnoses with artificial intelligence that gives consultants instant access to brain scan images. Russells Hall Hospital in Dudley introduced RapidAI in May 2024. The system speeds up triage – prioritising patients by urgency – by sending scans directly to consultants’ mobile phones. Since its introduction at [...]

  • Drug discovery company files patent for TBI drug

    Drug discovery company TauGen has filed a US patent application for a new series of drug candidates targeting endoplasmic reticulum (ER) stress – a key factor in secondary brain injury following traumatic brain injury (TBI). The company, owned by the board of directors of CereMark Pharma, has developed a platform of molecules designed to address [...]